Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Cardiovascular Systems Inc | csii10-kx63018.htm |
| EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Inc | ex322-63018.htm |
| EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Inc | ex321-63018.htm |
| EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Inc | ex312-63018.htm |
| EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Inc | ex311-63018.htm |
| EX-10.57 - EXHIBIT 10.57 - Cardiovascular Systems Inc | ex1057-secondleaseamendmen.htm |
| EX-10.26 - EXHIBIT 10.26 - Cardiovascular Systems Inc | ex1026-executiveseverancep.htm |
| EX-10.6 - EXHIBIT 10.6 - Cardiovascular Systems Inc | ex106fy19directorcompensatio.htm |
| EX-10.5 - EXHIBIT 10.5 - Cardiovascular Systems Inc | ex105-fy19execincentiveplan.htm |
| EX-10.4 - EXHIBIT 10.4 - Cardiovascular Systems Inc | ex104-fy19basesalaries.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-158755, 333-160609, 333-168682, 333-175703, 333-182668, 333-189856, 333-197348, 333-200214, 333-208137, and 333-221651) of Cardiovascular Systems, Inc. of our report dated August 23, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
August 23, 2018